1 Market Overview
1.1 Product Overview and Scope of Obstructive Uropathy Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Obstructive Uropathy Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Medical Treatement
1.3.3 Surgical Treatment
1.4 Market Analysis by Application
1.4.1 Overview: Global Obstructive Uropathy Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Obstructive Uropathy Treatment Market Size & Forecast
1.5.1 Global Obstructive Uropathy Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Obstructive Uropathy Treatment Sales Quantity (2018-2029)
1.5.3 Global Obstructive Uropathy Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boston Scientific Corporation
2.1.1 Boston Scientific Corporation Details
2.1.2 Boston Scientific Corporation Major Business
2.1.3 Boston Scientific Corporation Obstructive Uropathy Treatment Product and Services
2.1.4 Boston Scientific Corporation Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boston Scientific Corporation Recent Developments/Updates
2.2 Olympus Corporation
2.2.1 Olympus Corporation Details
2.2.2 Olympus Corporation Major Business
2.2.3 Olympus Corporation Obstructive Uropathy Treatment Product and Services
2.2.4 Olympus Corporation Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Olympus Corporation Recent Developments/Updates
2.3 Teleflex Incorporated
2.3.1 Teleflex Incorporated Details
2.3.2 Teleflex Incorporated Major Business
2.3.3 Teleflex Incorporated Obstructive Uropathy Treatment Product and Services
2.3.4 Teleflex Incorporated Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teleflex Incorporated Recent Developments/Updates
2.4 B. Braun Melsungen AG
2.4.1 B. Braun Melsungen AG Details
2.4.2 B. Braun Melsungen AG Major Business
2.4.3 B. Braun Melsungen AG Obstructive Uropathy Treatment Product and Services
2.4.4 B. Braun Melsungen AG Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 B. Braun Melsungen AG Recent Developments/Updates
2.5 Applied Medical
2.5.1 Applied Medical Details
2.5.2 Applied Medical Major Business
2.5.3 Applied Medical Obstructive Uropathy Treatment Product and Services
2.5.4 Applied Medical Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Applied Medical Recent Developments/Updates
2.6 AngioDynamics
2.6.1 AngioDynamics Details
2.6.2 AngioDynamics Major Business
2.6.3 AngioDynamics Obstructive Uropathy Treatment Product and Services
2.6.4 AngioDynamics Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AngioDynamics Recent Developments/Updates
2.7 Merit Medical Systems
2.7.1 Merit Medical Systems Details
2.7.2 Merit Medical Systems Major Business
2.7.3 Merit Medical Systems Obstructive Uropathy Treatment Product and Services
2.7.4 Merit Medical Systems Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merit Medical Systems Recent Developments/Updates
2.8 Argon Medical Devices, Inc.
2.8.1 Argon Medical Devices, Inc. Details
2.8.2 Argon Medical Devices, Inc. Major Business
2.8.3 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product and Services
2.8.4 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Argon Medical Devices, Inc. Recent Developments/Updates
2.9 optimed
2.9.1 optimed Details
2.9.2 optimed Major Business
2.9.3 optimed Obstructive Uropathy Treatment Product and Services
2.9.4 optimed Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 optimed Recent Developments/Updates
2.10 Cook Medical
2.10.1 Cook Medical Details
2.10.2 Cook Medical Major Business
2.10.3 Cook Medical Obstructive Uropathy Treatment Product and Services
2.10.4 Cook Medical Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cook Medical Recent Developments/Updates
2.11 C. R. Bard
2.11.1 C. R. Bard Details
2.11.2 C. R. Bard Major Business
2.11.3 C. R. Bard Obstructive Uropathy Treatment Product and Services
2.11.4 C. R. Bard Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 C. R. Bard Recent Developments/Updates
3 Competitive Environment: Obstructive Uropathy Treatment by Manufacturer
3.1 Global Obstructive Uropathy Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Obstructive Uropathy Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Obstructive Uropathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Obstructive Uropathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Obstructive Uropathy Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Obstructive Uropathy Treatment Manufacturer Market Share in 2022
3.5 Obstructive Uropathy Treatment Market: Overall Company Footprint Analysis
3.5.1 Obstructive Uropathy Treatment Market: Region Footprint
3.5.2 Obstructive Uropathy Treatment Market: Company Product Type Footprint
3.5.3 Obstructive Uropathy Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Obstructive Uropathy Treatment Market Size by Region
4.1.1 Global Obstructive Uropathy Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Obstructive Uropathy Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Obstructive Uropathy Treatment Average Price by Region (2018-2029)
4.2 North America Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.3 Europe Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.5 South America Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Obstructive Uropathy Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
5.2 Global Obstructive Uropathy Treatment Consumption Value by Type (2018-2029)
5.3 Global Obstructive Uropathy Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
6.2 Global Obstructive Uropathy Treatment Consumption Value by Application (2018-2029)
6.3 Global Obstructive Uropathy Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
7.2 North America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
7.3 North America Obstructive Uropathy Treatment Market Size by Country
7.3.1 North America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Obstructive Uropathy Treatment Market Size by Country
8.3.1 Europe Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Obstructive Uropathy Treatment Market Size by Region
9.3.1 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
10.2 South America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
10.3 South America Obstructive Uropathy Treatment Market Size by Country
10.3.1 South America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Obstructive Uropathy Treatment Market Size by Country
11.3.1 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Obstructive Uropathy Treatment Market Drivers
12.2 Obstructive Uropathy Treatment Market Restraints
12.3 Obstructive Uropathy Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Obstructive Uropathy Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Obstructive Uropathy Treatment
13.3 Obstructive Uropathy Treatment Production Process
13.4 Obstructive Uropathy Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Obstructive Uropathy Treatment Typical Distributors
14.3 Obstructive Uropathy Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Obstructive Uropathy Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Obstructive Uropathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Corporation Major Business
Table 5. Boston Scientific Corporation Obstructive Uropathy Treatment Product and Services
Table 6. Boston Scientific Corporation Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boston Scientific Corporation Recent Developments/Updates
Table 8. Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Olympus Corporation Major Business
Table 10. Olympus Corporation Obstructive Uropathy Treatment Product and Services
Table 11. Olympus Corporation Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Olympus Corporation Recent Developments/Updates
Table 13. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors
Table 14. Teleflex Incorporated Major Business
Table 15. Teleflex Incorporated Obstructive Uropathy Treatment Product and Services
Table 16. Teleflex Incorporated Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teleflex Incorporated Recent Developments/Updates
Table 18. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 19. B. Braun Melsungen AG Major Business
Table 20. B. Braun Melsungen AG Obstructive Uropathy Treatment Product and Services
Table 21. B. Braun Melsungen AG Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. B. Braun Melsungen AG Recent Developments/Updates
Table 23. Applied Medical Basic Information, Manufacturing Base and Competitors
Table 24. Applied Medical Major Business
Table 25. Applied Medical Obstructive Uropathy Treatment Product and Services
Table 26. Applied Medical Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Applied Medical Recent Developments/Updates
Table 28. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 29. AngioDynamics Major Business
Table 30. AngioDynamics Obstructive Uropathy Treatment Product and Services
Table 31. AngioDynamics Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AngioDynamics Recent Developments/Updates
Table 33. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 34. Merit Medical Systems Major Business
Table 35. Merit Medical Systems Obstructive Uropathy Treatment Product and Services
Table 36. Merit Medical Systems Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merit Medical Systems Recent Developments/Updates
Table 38. Argon Medical Devices, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Argon Medical Devices, Inc. Major Business
Table 40. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product and Services
Table 41. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Argon Medical Devices, Inc. Recent Developments/Updates
Table 43. optimed Basic Information, Manufacturing Base and Competitors
Table 44. optimed Major Business
Table 45. optimed Obstructive Uropathy Treatment Product and Services
Table 46. optimed Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. optimed Recent Developments/Updates
Table 48. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 49. Cook Medical Major Business
Table 50. Cook Medical Obstructive Uropathy Treatment Product and Services
Table 51. Cook Medical Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cook Medical Recent Developments/Updates
Table 53. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 54. C. R. Bard Major Business
Table 55. C. R. Bard Obstructive Uropathy Treatment Product and Services
Table 56. C. R. Bard Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. C. R. Bard Recent Developments/Updates
Table 58. Global Obstructive Uropathy Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Obstructive Uropathy Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Obstructive Uropathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Obstructive Uropathy Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Obstructive Uropathy Treatment Production Site of Key Manufacturer
Table 63. Obstructive Uropathy Treatment Market: Company Product Type Footprint
Table 64. Obstructive Uropathy Treatment Market: Company Product Application Footprint
Table 65. Obstructive Uropathy Treatment New Market Entrants and Barriers to Market Entry
Table 66. Obstructive Uropathy Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Obstructive Uropathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Obstructive Uropathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Obstructive Uropathy Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Obstructive Uropathy Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Obstructive Uropathy Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Obstructive Uropathy Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Obstructive Uropathy Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Obstructive Uropathy Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Obstructive Uropathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Obstructive Uropathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Obstructive Uropathy Treatment Raw Material
Table 126. Key Manufacturers of Obstructive Uropathy Treatment Raw Materials
Table 127. Obstructive Uropathy Treatment Typical Distributors
Table 128. Obstructive Uropathy Treatment Typical Customers
List of Figures
Figure 1. Obstructive Uropathy Treatment Picture
Figure 2. Global Obstructive Uropathy Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Obstructive Uropathy Treatment Consumption Value Market Share by Type in 2022
Figure 4. Medical Treatement Examples
Figure 5. Surgical Treatment Examples
Figure 6. Global Obstructive Uropathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Obstructive Uropathy Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Obstructive Uropathy Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Obstructive Uropathy Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Obstructive Uropathy Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Obstructive Uropathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Obstructive Uropathy Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Obstructive Uropathy Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Obstructive Uropathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Obstructive Uropathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Obstructive Uropathy Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Obstructive Uropathy Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Obstructive Uropathy Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Obstructive Uropathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Obstructive Uropathy Treatment Market Drivers
Figure 74. Obstructive Uropathy Treatment Market Restraints
Figure 75. Obstructive Uropathy Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Obstructive Uropathy Treatment in 2022
Figure 78. Manufacturing Process Analysis of Obstructive Uropathy Treatment
Figure 79. Obstructive Uropathy Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
| ※参考情報 閉塞性尿路疾患治療は、尿路が何らかの原因で閉塞してしまい、尿の流れが阻害される状態に対して行われる治療の総称です。閉塞性尿路疾患は、腎臓から膀胱に至る尿の排出経路のどこかに障害が生じることによって引き起こされます。この疾患は、急性または慢性の状態として現れることがあります。急性の場合、症状は比較的突然に現れ、迅速な対応が求められます。一方、慢性のケースでは、長期間にわたって徐々に進行するため、症状が軽微であることが多いですが、放置すると重篤な合併症を引き起こす可能性があります。 閉塞性尿路疾患の主な特徴としては、尿の流れが妨げられることにより、腎機能が低下し、最終的には腎不全に至るリスクが高まることが挙げられます。尿の溜まりが増えることで、腎臓にかかる圧力が上昇し、それが長期間続くと腎組織が損傷し、不可逆的な障害を引き起こすこともあります。また、閉塞が発生する位置によって症状や治療法が異なるため、診断と適切な治療のためには、原因の特定が重要です。 閉塞性尿路疾患には、いくつかの種類があります。腎結石、尿道狭窄、前立腺肥大、腫瘍（悪性または良性）、尿管の異常などがよく見られる原因です。腎結石は、尿中の結晶が集まってできたもので、特に痛みを伴うことが多く、尿の通過を阻害します。尿道狭窄は、尿道が狭くなり、尿の流れが困難になる状態で、外傷や手術後の癒着などが原因となることが多いです。前立腺肥大は、中高年の男性によく見られる状態で、前立腺が肥大することによって尿道が圧迫され、排尿困難を引き起こします。腫瘍は、尿路のどの部位にも発生する可能性があり、閉塞性尿路疾患を引き起こす重要な因子となります。 このような疾患に対する治療方法は、原因に応じて異なります。基本的には、閉塞を解消し、尿の流れを正常に戻すことが治療の目標です。もし原因が結石であれば、結石を体外に排出させるための治療が行われます。小さな結石であれば自然排出を促す薬剤を使用することもありますが、大きな結石の場合は、体外衝撃波结石破砕術（ESWL）や尿路内視鏡下での手術が行われます。尿道狭窄の場合には、まずは狭窄部位を拡張することが考えられます。バルーン拡張術や、尿道ステントを用いることが一般的です。また、狭窄が重度である場合には、手術によって狭窄部位を切除し、尿道を再構築する必要があるかもしれません。 前立腺肥大に対する治療は、薬物療法か手術療法が考慮されます。薬物療法では、α-ブロッカーや5α還元酵素阻害剤を使用することで、前立腺のサイズを縮小し、症状の改善を目的とします。手術療法では、経尿道的前立腺切除術（TURP）などの手術が行われ、尿道を圧迫している前立腺の部分を切除します。腫瘍が原因である場合には、基本的に腫瘍の切除が考えられますが、その際には悪性度によって化学療法や放射線療法が併用されることもあります。 患者の体調や年齢、病歴によって選択する治療法は異なるため、医師が個別に適切な治療法を提案することが求められます。また、治療だけでなく、予防についても意識を持つことが重要です。尿路感染症や結石のリスクを少なくするためには、適切な水分の摂取、日常生活での注意が必要です。これにより、閉塞性尿路疾患の発症を予防し、健康的な尿路機能を維持することができます。 技術的な面では、画像診断が重要な役割を果たします。超音波、CT、MRIなどが用いられ、閉塞の原因や程度を正確に把握するための手段となります。これらの技術を駆使することで、より精密な治療計画を立てることが可能になります。また、内視鏡的手技も、尿路の構造を直に確認しながら治療を行う際には欠かせない技術です。内視鏡を用いることで、痛みを最小限に抑えながら、的確かつ迅速に閉塞を解消することができます。 閉塞性尿路疾患治療は、しばしば多岐にわたる専門分野の協力を必要とするため、泌尿器科医、放射線科医、病理医、看護師、さらには場合によっては腫瘍専門医など、多くの医療従事者が連携して治療にあたります。これにより、患者一人ひとりに最適な治療方法を提供し、良好な予後を目指すことができるのです。治療後も定期的なフォローアップや生活指導を行い、再発を予防するための取り組みが重要です。 閉塞性尿路疾患治療は、非常に多様なアプローチを必要とする複雑な領域です。患者の症状や疾患の進行状況、さらには生活スタイルに応じた治療が求められます。そのため、医療機関では、専門的な知識と技術を持つ医療チームが、患者に寄り添った治療を行うことが必要です。急を要する場合もあれば、慢性的な管理が求められる場合もありますが、すべての患者にとって、適切な治療とその後のケアが生活の質を高める鍵となります。現代の医療技術は進歩を続けており、今後も閉塞性尿路疾患の治療における新しい手法や技術が開発され、さらなる成果をもたらすことが期待されています。降圧的な治療法や予防策も進化し、多くの患者がより健康的な生活を送れるようになることを願っています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
